Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Alonso

Showing results (221-230 of 266) with videos related to

Pageof 27
Sort By:
JAMA Internal Medicine|November 13, 2018
Effect of Exercise Intervention on Functional Decline in Very Elderly Patients During Acute Hospitalization: A Randomized Clinical TrialNicolás Martínez-Velilla, Alvaro Casas-Herrero, Fabricio Zambom-Ferraresi, et al.
International Journal of Cardiology|April 20, 2023
Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictorsJosé M Serrano, Rebeca Mata, Iria González, et al.
Experimental Eye Research|January 8, 2025
Mosaicism and intronic variants in RB1 gene revealed by next generation sequencing in a cohort of Spanish retinoblastoma patientsGema Gomez-Mariano, Esther Hernandez-SanMiguel, Marta Fernandez-Prieto, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 23, 2024
Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA studyVicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, et al.
Clinical Breast Cancer|January 29, 2025
Identification and Management of Medical Comorbidities in Patients With HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Literature Review and Recommendations From Experts in Spain OpinionCarmen Hinojo, Blanca Cantos, Silvia Antolín, et al.
Nanomedicine (London, England)|January 9, 2023
Multifunctional nanocarriers of Fe<sub>3</sub>O<sub>4</sub>@PLA-PEG/curcumin for MRI, magnetic hyperthermia and drug deliveryPhan Quoc Thong, Le Thi Thu Huong, Nguyen Dac Tu, et al.
Journal of Human Genetics|November 28, 2019
Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype-phenotype relationshipsCarlos Rodríguez-Martín, Cristina Robledo, Gema Gómez-Mariano, et al.
Ebiomedicine|March 28, 2024
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcomaVerónica Rey, Juan Tornín, Juan Jose Alba-Linares, et al.
Pharmacogenetics and Genomics|September 30, 2017
Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancerSara Ruiz-Pinto, Guillermo Pita, Ana Patiño-García, et al.
Orphanet Journal of Rare Diseases|February 12, 2020
Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrumRoser Urreizti, Estrella Lopez-Martin, Antonio Martinez-Monseny, et al.
Pageof 27

Showing results (221-230 of 266) with videos related to

Sort By:
Pageof 27
JAMA Internal Medicine|November 13, 2018
Effect of Exercise Intervention on Functional Decline in Very Elderly Patients During Acute Hospitalization: A Randomized Clinical TrialNicolás Martínez-Velilla, Alvaro Casas-Herrero, Fabricio Zambom-Ferraresi, et al.
International Journal of Cardiology|April 20, 2023
Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictorsJosé M Serrano, Rebeca Mata, Iria González, et al.
Experimental Eye Research|January 8, 2025
Mosaicism and intronic variants in RB1 gene revealed by next generation sequencing in a cohort of Spanish retinoblastoma patientsGema Gomez-Mariano, Esther Hernandez-SanMiguel, Marta Fernandez-Prieto, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 23, 2024
Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA studyVicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, et al.
Clinical Breast Cancer|January 29, 2025
Identification and Management of Medical Comorbidities in Patients With HR+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Literature Review and Recommendations From Experts in Spain OpinionCarmen Hinojo, Blanca Cantos, Silvia Antolín, et al.
Nanomedicine (London, England)|January 9, 2023
Multifunctional nanocarriers of Fe<sub>3</sub>O<sub>4</sub>@PLA-PEG/curcumin for MRI, magnetic hyperthermia and drug deliveryPhan Quoc Thong, Le Thi Thu Huong, Nguyen Dac Tu, et al.
Journal of Human Genetics|November 28, 2019
Frequency of low-level and high-level mosaicism in sporadic retinoblastoma: genotype-phenotype relationshipsCarlos Rodríguez-Martín, Cristina Robledo, Gema Gómez-Mariano, et al.
Ebiomedicine|March 28, 2024
A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcomaVerónica Rey, Juan Tornín, Juan Jose Alba-Linares, et al.
Pharmacogenetics and Genomics|September 30, 2017
Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancerSara Ruiz-Pinto, Guillermo Pita, Ana Patiño-García, et al.
Orphanet Journal of Rare Diseases|February 12, 2020
Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrumRoser Urreizti, Estrella Lopez-Martin, Antonio Martinez-Monseny, et al.
Pageof 27